Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 5/20 | 0.34 |
| ▸ | CA2 | P00918 | 5/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.33 |
| ▸ | TYMS | P04818 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13764199 | 0.90 | CA1 (0.37) | POLBALDH1A1HSD17B10KDM4ECA1 | |
| SCHEMBL13764189 | 0.86 | CA1 (0.38) | POLBALDH1A1HSD17B10KDM4ECA1 | |
| SCHEMBL13764273 | 0.86 | TSHR (0.40) | POLBALDH1A1KDM4ECA1CA2 | |
| SCHEMBL13764230 | 0.85 | POLB (0.38) | POLBALDH1A1HSD17B10KDM4ECA1 | |
| SCHEMBL12141401 | 0.84 | SCN3A (0.46) | ALDH1A1KDM4ELMNAHPGDMAPT | |
| SCHEMBL13995229 | 0.83 | POLB (0.38) | POLBALDH1A1HSD17B10KDM4ECA1 | |
| SCHEMBL13764286 | 0.82 | POLB (0.36) | POLBALDH1A1HSD17B10KDM4ELMNA | |
| SCHEMBL13993739 | 0.81 | POLB (0.38) | POLBALDH1A1HSD17B10KDM4ECA1 | |
| SCHEMBL12141375 | 0.80 | CA1 (0.36) | POLBALDH1A1HSD17B10KDM4ECA1 | |
| SCHEMBL12141431 | 0.79 | ALDH1A1 (0.40) | ALDH1A1KDM4ECA1CA2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7557176-B2 | Polyhydroxyalkanoic acid having vinyl, ester, carboxyl or sulfonic acid group and producing method therefor | CANON KABUSHIKI KAISHA (JP) | 2009-07-07 | — | — | US | disclosed |
| US-20080064828-A1 | Polyhydroxyalkanoic Acid Having Vinyl, Ester, Carboxyl or Sulfonic Acid Group and Producing Method Therefor | CANON KABUSHIKI KAISHA (JP) | 2008-03-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080064828-A1 | Polyhydroxyalkanoic Acid Having Vinyl, Ester, Carboxyl or Sulfonic Acid Group and Producing Method Therefor | FAR1, ACSL4, ACAD11 | POLB 3440/4885ALDH1A1 224/4885HSD17B10 112/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.